Abu Dhabi - Mubasher: Burjeel Holdings logged net profits after tax amounting to AED 362.03 million in the first nine months (9M) of 2025, up year-on-year (YoY) from AED 306.22 million.
Revenues hiked to AED 4.09 billion in 9M-25 from AED 3.70 billion a year earlier, according to the financial results.
Basic and diluted earnings per share (EPS) went up to AED 0.07 at the end of September 2025 from AED 0.06 in 9M-24.
Financials for Q3-25
In the third quarter (Q3) of 2025, the group’s net profits hiked to AED 175.17 million from AED 137.34 million in Q3-24. Revenues jumped to AED 1.42 billion from AED 1.31 billion.
John Sunil, CEO of Burjeel Holdings, said: “Strategic investments in recent years have made the group one of the region’s most resilient and trusted healthcare ecosystems, with a well-balanced brand portfolio and strong alignment with the UAE’s national vision.”
“Our results demonstrate operational efficiency, clinical excellence, and robust financial momentum. The group has established itself as the region’s foremost destination for complex and high-acuity care, encompassing oncology, organ transplantation, and advanced surgical specialties, with world-class capabilities now extending across the GCC,” he added.
During the six-month period that ended on 30 June 2025, the ADX-listed company posted net profits valued at AED 186.86 million.
